TD Cowen Reiterates Buy on Eli Lilly, Maintains $1250 Price Target

TD Cowen analyst Steve Scala has reiterated a Buy rating on Eli Lilly (NYSE: LLY) and maintained a price target of $1250 for the stock. This endorsement reflects confidence in the company's performance and market position.